The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 2 study of ISA101b (peltopepimut-S) and cemiplimab in patients with advanced HPV16+ oropharyngeal cancer who failed anti-PD1 therapy.
 
Anthony H Kong
Honoraria - MSD/Merck
Consulting or Advisory Role - MSD/Merck
Speakers' Bureau - MSD/Merck
Research Funding - AstraZeneca (Inst)
 
Marielle S Klein Hesselink
Employment - ISA Pharmaceuticals; Merck KGaA
 
Begoña Aguilera
Employment - ISA Pharmaceuticals
 
Douglas Adkins
Consulting or Advisory Role - Boehringer Ingelheim; Calliditas Therapeutics; CUE Biopharma; Eisai Europe; Exelixis; Genmab/Seattle Genetics; Gilead Sciences; Immunitas; Jazz Pharmaceuticals; Kura Oncology; Merck; Seagen; TargImmune Therapeutics; Vaccinex
Research Funding - Adlai Nortye (Inst); AstraZeneca (Inst); BeiGene (Inst); BioAtla (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Calliditas Therapeutics (Inst); Celgene (Inst); Cofactor Genomics (Inst); CUE Biopharma (Inst); Debiopharm Group (Inst); Epizyme (Inst); Genmab (Inst); Gilead Sciences (Inst); Hookipa Biotech (Inst); Immutep (Inst); ISA Pharmaceuticals (Inst); Kura Oncology (Inst); Lilly (Inst); Merck (Inst); NATCO Pharma (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst); Tizona Therapeutics, Inc. (Inst); Vaccinex (Inst)
 
Caroline Even
Consulting or Advisory Role - Bristol-Myers Squibb; Fstar Therapeutics (Inst); Innate Pharma; Merck Serono; MSD Oncology; Novartis (Inst)
Travel, Accommodations, Expenses - Merck Serono; Merck Serono; MSD Oncology
 
Jerome Fayette
Honoraria - AstraZeneca; Bristol-Myers Squibb; Hookipa Pharma; Merck Serono; Merck Sharp & Dohme; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Elevar Therapeutics; Hookipa Pharma; ITeos Therapeutics; Merck Serono; Merck Sharp & Dohme; Seagen
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme
 
Jameel Muzaffar
No Relationships to Disclose
 
Sonja Visscher
Employment - ISA Pharmaceuticals
 
Cornelis JM Melief
Employment - ISA Pharmaceuticals
Stock and Other Ownership Interests - ISA Pharmaceuticals
Patents, Royalties, Other Intellectual Property - I am holder of 10 approved patents from Leiden University Medical Center. These patents have been licensed to ISA Pharmaceuticals. They will lead to payments to me from the leiden University Medical Center, when the company is bale to market a product bas
 
Leon W. Hooftman
Employment - ISA Pharmaceuticals
Stock and Other Ownership Interests - ISA Pharmaceuticals
Honoraria - ISA Pharmaceuticals
Research Funding - ISA Pharmaceuticals
Travel, Accommodations, Expenses - ISA Pharmaceuticals